Turn Therapeutics earnings were -$8.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TTRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$5.8M, up 502.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TTRX reported annual earnings of -$3.2M, with 80.6% growth.
What were Turn Therapeutics's earnings last quarter?
On TTRX's earnings call on Aug 10, 2026, Turn Therapeutics (NASDAQ: TTRX) reported Q2 2026 earnings per share (EPS) of -$0.20, up 300% year over year. Total TTRX earnings for the quarter were -$5.85 million. In the same quarter last year, Turn Therapeutics's earnings per share (EPS) was -$0.05.
As of the last Turn Therapeutics earnings report, Turn Therapeutics is currently losing money. Turn Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$8.45 million, a 230.1% increase year over year.
What was TTRX's earnings growth in the past year?
As of Turn Therapeutics's earnings date in Aug 10, 2026, Turn Therapeutics's earnings has grown year over year. TTRX earnings in the past year totalled -$8.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.